Viewing data from:

VIENVA

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A201088 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Vienva (2023)

Total Spending

$290K

Total Claims

10,845

Beneficiaries

2,517

Avg Cost/Unit

$0.48

Spending Trend

$159K(2019)→$201K(2020)→$237K(2021)→$271K(2022)→$290K(2023)

YoY Change:-1.0%

5yr CAGR:-4.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG;0.1MG

AB1

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: May 21, 2015

No patent or exclusivity listings for this strength.